Urolithiasis in adults. Clinical and biochemical aspects

Saudi Medical Journal

Volumn 26, Issue 5, 2005, Pages 705-713

  Abdel Halim, Rabie E ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CITRATE POTASSIUM; DRINKING WATER; FAT; MAGNESIUM CITRATE; OXALIC ACID; PROTEIN; TAP WATER; URIC ACID;

CALCIUM INTAKE; DISEASE ASSOCIATION; EXTRACORPOREAL LITHOTRIPSY; FAMILY HISTORY; FAT INTAKE; FLUID INTAKE; HUMAN; HYPERCALCIURIA; HYPEROXALURIA; HYPERURICOSURIA; INCIDENCE; LIPID DIET; NUTRIENT; OBESITY; OVERNUTRITION; PROTEIN DIET; RECURRENT DISEASE; REVIEW; RISK FACTOR; RURAL AREA; SEASONAL VARIATION; TEMPERATURE; URBAN AREA; URINE PH; URINE VOLUME; UROLITHIASIS; WATER HARDNESS;

ADULT; CALCIUM; DIET; DRINKING; FEMALE; HUMANS; MALE; OXALATES; OXALIC ACID; RISK FACTORS; URIC ACID; URINARY CALCULI;

EID: 21344457262     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (142)

1. Clark JY, Thompson IM, Optenberg SA. Economic impact of Urolithiasis in the United States. J Urol 1995; 154: 2020-2024.
2. Gregory JG. Hyperoxaluria and stone disease in the gastrointestinal bypass patient. Urol Clin North Am 1981; 8: 331-351.
3. Rose GA. An overview of some problem in urolithiasis. In: Urinary stones clinical and laboratory aspects. Lancaster: MTP Press; 1982. p. 1-41.
4. Kassimi MA, Abdel-Halim RE, Hardy MJ. The problem of urinary tract stones in the Western Region of Saudi Arabia. Saudi Med J 1986; 7: 394-401.
5. Cutajar CL. The role of Schistosomiasis in urolithiasis. Br J Urol 1983; 55: 349-352.
6. Taha S, Mitry NF, Hiondi G. The pattern of urinary calculi in the Eastern Province of Saudi Arabia. Arab Journal of Medicine; 1985: 4: 4-8.
7. Abomelha MS, Al-Khader AA, Arnold J. Urolithiasis in Saudi Arabia. J Urology 1990; 35: 31-34.
8. Ekman P, Husain I, Sharma ND, Al-Faqih, SR. Transurethral ureteroscopy - Safety guide wire as an aid to a more aggressive approach. Br J Urol 1987; 60: 23-27.
9. Abdel-Halim RE. Some observations on the operative management of renal stones. In: Ryall R, Brockis JG, Marshall V, Finlayson B, editors. Urinary Stone. Melbourne, Edinburgh, London, New York: Churchill Livingstone; 1984. p. 125-130.
10. Husain I, Badsha SA, Al-Ali IH, Walton M, Sahab A, Jaffree S. A Survey of urinary stone disease in Abu Dhabi. Emirate Medical Journal 1979; I Supplement 1: 17-33.
11. Romero Perez P, Amat Cecilia M. Epidemiology of urinary calculi in the Marina Alta (Alicante) region. Actas Urol Esp 1992; 16: 455-461.
12. Mkony CA. Urinary stone disease in Tanzania: an insight into the magnitude of the problem. East Afr Med J 1993; 70: 565-567.
13. Scott R, Freeland R, Mowat W, Paterson PJ, Orr PS, Yates AJ, et al. The prevalence of renal stones in a random population and volunteer population. In: Brockis JG, Finlayson B, editors. Urinary calculus, International Urinary Conference. Littleton (MA): PSG Publishing Company; 1981. p. 65-88.
14. Ljunghall S. Regional variations in the incidence of urinary stones. Letter to the editor. Br Med J 1978; 18: 440.
15. Ljunghall S, Christensson T, Wengle B. Prevalence and incidence of renal stone disease in a health screening programme. Scand J Urol Nephrol 1977; Supplementum 41: 39-54.
16. Scott R, Freeland R, Mowat W, Gardiner M, Hawthorne V, Marshall RM, et al. The prevalence of calcified upper urinary tract stone disease in a random population. Cumberland Health Survey. Br J Urol 1977; 49: 589-594.
17. Johnson CM, Wilson DM, O'Fallon WM, Malek RS, Kurland LT. Renal stone epidemiology: A 25 year study in Rochester, Minnesota. Kidney Int 1979; 16: 624-631.
18. Hesse A, Bach D, Vahlensieck W. Epidemiological studies in urolithiasis in West Germany. In: Brockis G, Finlayson B editors. Urinary calculus. Proceedings of the International Urinary Stone Conference, Perth, Australia, 1979. Littleton (MA): PSG Publishing Company; 1980. p. 13-24.
19. Vahlensieck W, Bach D, Hesse A. Incidence, prevalence and mortality of urolithiasis in the German Federal Republic. Urol Res 1982; 10: 161-164.
20. Reyes RL, Mirabal MM, Strusser GR. Clinico-epidemiologic behavior of urolithiasis in a rural Caribbean region. Arch Esp Urol 2002; 55: 527-533.
21. Abdel-Halim RE, Baglaf AO, Sibaei AI, Merzibani M, Hadrami MS, Noorwali et al. Urolithiasis in the Western Region of Saudi Arabia: A clinical, biochemical and epidemiological study, Riyadh (KSA): King Abdul-Aziz City for Science and Technology; 1996. p. 74-278.
22. Vahlensieck EW, Bach D, Hesse A, Strenge A. Epidemiology, Pathogenesis and diagnosis of calcium oxalate urolithiasis. Int Urol Nephrol 1982; 14: 333-347.
23. Robertson WG, Peacock M, Baker M, Marshall DH, Pearlman B, Speed R et al. Studies on the prevalence and epidemiology of urinary stone disease in men in Leeds. Br J Urol 1983; 55: 595-598.
24. Hiatt RA, Dales LG, Friedman GD, Hunkeler EM. Frequency of urolithiasis in a prepaid medical care program. Am J Epid 1982; 115: 255-265.
25. Scott R. Prevalence of calcified upper urinary tract stone disease in a random population survey. Br J Urol 1987; 59: 111-117.
26. Tschope W, Ritz E, Haslbeck M, Mehnert, Wesch H. Prevalence and incidence of renal stone disease in a German population sample. Klin Wochenschr 1981; 59: 411-412.
27. Abdel-Halim RE, Baghlaf AO Farag AB. Clinical chemical study of urinary stones in Saudi Arabia. I - Uric Acid stones. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W, editors. Urolithiasis and related clinical research. New York, London: Plenum Press; 1985. p. 715-718.
28. Abdel-Halim RE, Baghlaf A, Farag AB. Clinico-chemical study of urinary stones in Jeddah: II. Oxalate stones, In: Jardin A et al, editors. Proceedings of the XXe Congres de la Société Internationale Urologie. Paris: la Société Internationale Urologie; 1985. p. 221.
29. Khan AS, Rai ME, Gandapur AS, Shah AH, Hussain AA, Siddiq M. Epidemiological risk factors and composition of urinary stones in Riyadh, Saudi Arabia. J Ayub Med Coll Abbottabad 2004; 16:56-58.
30. Al-Rasheed SA, El-Faqih SR, Husain I, Abdurrahman M, Al-Mugeirin MM. The aetiological and clinical pattern of childhood urolithiasis in Saudi Arabia. Int Urol Nephrol 1995; 27: 349-355.
31. Ibrahim A, Zein M, Beleil O. Clinical aspects of urolithiasis in the Sudan. J R Coll Surg 1979; 24: 34-39.
32. Al-Naama LM, Luay SP, Baqir YA, Rasoul HA, Abdel-Khaddar M. Incidence and composition of urinary stones in Southern Iraq. Saudi Med J 1987; 8: 456.
33. Dajani AM, Abu Khadra A. Urinary calculi and urinary tract infection. In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG, editors. Urolithiasis. London, New York: Plenum Press; 1989. p. 277-278.
34. Blacklock NJ. Epidemiology of urolithiasis. In: Chisholm GD, Williams DI, editors. Scientific foundation of Urology. 2nd ed. London (UK): William Heineman Medical Books; 1982. p. 251-259.
35. Koide T, Itatani H, Yoshioka T, Ito H, Namiki M, Nakano E, et al. Clinical manifestations of calcium oxalate monohydrate and dihydrate urolithiasis. J Urol 1982; 127: 1067-1069.
36. Hodgkinson A. Composition of urinary tract calculi in children of different ages. Br J Urol 1977; 49: 453-455.
37. Hodgkinson A. Composition of urinary tract calculi from some developing countries. Urol Int 1979; 34: 26-35.
38. Drach GW, Randolph AD, Miller JD. Inhibition of calcium oxalate dihydrate crystallization by chemical modifier. J Urol 1978; 119: 99-103.
39. Westbury EJ. Some observations on the quantitative analysis of over 1000 calculi. Br J Urol 1974; 46: 215-227.
40. Almby B, Meirik O, Schönebeck J. Incidence, morbidity and complications of renal and ureteral calculi in a well-defined geographical area. Scan J Urol Nephrol 1975; 9: 249-253.
41. Barker DJP, Dorman SPB. Regional variations in the incidence of upper urinary tract stones in England and Wales. Br Med J 1978; 1: 67-70.
42. Power C, Barker DJP, Blacklock NJ. Incidence of renal stones in 18 British towns, a collaborative study. Br J Urol 1987; 59: 105-110.
43. Borghi L, Ferretti PP, Elia GF, Amato F, Melloni E, Trapassi MR, et al. Epidemiological study of urinary tract stones in a Northern Italian city. Br J Urol 1990; 65: 231-235.
44. Williams RE. Long-term survey of 538 patients with upper urinary tract stone. Br J Urol 1963; 35: 416-437.
45. Lenaghan D. Urinary calculi and their incidence in New Australian migrants. Med J Aust 1965; 2: 65-73.
46. Lavan JN, Neale FC, Posen S. Urinary calculi. Clinical, Biochemical and Radiological studies in 619 patients. Med J Aust 1971; 2: 1049-1061.
47. Rous SN. A review of 171 consecutive patients with urinary lithiasis. J Urol 1981; 126: 376-379.
48. Foo KT, Tung KH, Tan EC, Lin CT, Foong WC. The pattern of urinary stone disease in a surgical department in Singapore, In: Ryall Rosemary L, Brockis JG, Marshall V, Finalyson B, editors. Urinary stone. Melbourne, Edinburgh, London, New York: Churchill Livingstone; 1984: 80-85.
49. Reis-Santos JM. Epidemiological Risk Factors in the South of Portugal. In: Jardin et al, editors. Proceedings of the XXe Congress de la Societe Internationale Urologie. Paris: la Société Internationale Urologie; 1985. p. 244-246.
50. Ljunghall S, Danielson BG, Fellstrom B, Holmgren K, Johansson G, Wilkstrom B. Family history of renal stones in recurrent stone patients. Br J Urol 1985; 57: 370-374.
51. Koide T, Oka T, Takaha M, Sonoda T. Urinary Tract Stone Disease in Modern Japan. Eur Urol 1986; 12: 403-407.
52. Robertson WJ, Peacock M, Heyburn PJ. Risk factors in calcium stone disease of the urinary tract. Br J Urol 1978; 50: 449-454.
53. Elliot JS. Calcium oxalate urinary calculi: Clinical and chemical aspects. Medicine 1983; 62: 36-43.
54. Leonetti F, Dussol B, Berthezene P, Thirion X, Berland Y. Dietary and urinary risk factors for stones in idiopathic calcium stone formers compared with healthy subjects. Nephrol Dial Transplant 1998; 13: 617-622.
55. Ibrahim A. Urinary lithogenesis in Sudanese patients: A study on 125 stone formers. J Urol 1979; 121: 572-574.
56. Ombra MN, Casula S, Biino G, Maestrale G, Cardia F, Melis P, et al. Urinary glycosaminoglycans as risk factors for uric acid nephrolithiasis: case control Study in a Sardinian cenetic isolate. J Urol 2003; 2: 416-420.
57. Tiselius HG, Larsson, L. Urianary exretion of urate in patients with calcium oxalate stone disease. Urol Res 1983; 11: 279-283.
58. Tiselius HG. The effect of pH on the urinary inhibition of calcium oxalate crystal growth. Br Urol 1981; 53: 470-474.
59. Zambreski PM, Hedley AJ, Al-Beteri A, Karim A, Paterson CR. Some studies on bladder stones from the north eastern region of Thailand. In: Brockis JG, Finlayson B, editors. Urinary calculus. International Urinary Stone Conference. Littleton (MA): PSG Publishing Company; 1982. p. 371-392.
60. Pak CY, Poindexter JR, Peterson RD, Koska J, Sakhaee K. Biochemical distinction between hyperuricosuric calcium urolithiasis and Gouty diathesis. J Urol 2002; 60: 789-794.
61. Kinder JM, Clark CD, Coe BJ, Asplin JR, Parks JH, Coe FL. Urinary stone risk factors in the siblings of patients with calcium renal stones. J Urol 2002; 167: 1965-1967.
62. Brown DC. Kidney Stones. Current issues In Diagnosis and Therapy. Postgrad Med 1982; 72: 124-128.
63. Hanash KA, Bissada NK, Woodhouse NJY. Pattern of calcium metabolism in normo and hyper calciuric patients with calcium urolithiasis in Saudi Arabia. J Urol 1985; 26: 27-32.
64. Thomas J, Thomas E, Charranson-Maistre G, Barthelemy C, Sleiman B, Desgrez P, et al. An Epidemiologic Study of Calcium Oxalate Lithiasis. Urinary Calcium and Oxalate Exretion. Sem Hop Paris 1987; 63: 1491-1498.
65. Berlin T. Proposed criteria for identifying hyperabsorbers among normocalcemic renal stone formers. Scand J Urol Nephrol 1987; 21: 103-107.
66. Parent X, Boess G, Brignon P. Calcium oxalate lithiasis. Relationship between biochemical risk factors and crystalline phase of the stone. J Prog Urol 1999; 9: 1051-1056.
67. Pak CYC, Ohate M, Lawrence EC, Snyder W. The hypercalciurias: Causes, parathyroid function and diagnostic criteria. J Clin Invest 1974; 54: 387-400.
68. Yagisawa T, Chandhoke PS, Fan J. Metabolic risk factors in patients with first- time and recurrent stone formations as determined by comprehensive metabolic evaluation. J Urol 1998; 52: 750-755.
69. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Twenty four hour urine chemistries and the risk of kidney stones among women and men. Kidney Int 2001; 59: 2290-2298.
70. Siener R, Glatz S, Nicolay C, Hesse A. Prospective study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium oxalate stone patients. Eur Urol 2003; 44: 467-474.
71. Mittal RD, Kumar R, Mittal B, Prasad R, Bhandari M. Stone composition, metabolic profile and the presence of the gut inhabiting bacterium oxalobacter formigenes as risk factors for renal stone formation. Med Princ Pract 2003; 12: 208-213.
72. Koide T, Bowyer RC, Brockis JG. Comparison of urinary oxalate excretion in urolithiasis patients with and without hypercalciuria. Br J Urol 1985; 57: 505-509.
73. Pak CYC, Bretton F, Peterson R. Ambulatory evaluation of nephrolithiasis classification, chemical presentation and diagnostic criteria. Am J Med 1980; 69: 19-30.
74. Pak CYC, Peterson R, Poindexter JR. Adequacy of a single stone risk analysis in the medical evaluation of Urolithiasis. J Urol 2001; 165: 378-381.
75. Pizzato AC, Barros EJG. Dietary calcium intake among patients with urinary calculi. Nutr Res 2003; 23: 1651-1660.
76. Coe FE, Kavalach AG. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med 1974; 291: 2344-2350.
77. Boss GR, Seegmiller JE. Hyperuricemia and gout. N Engl J Med 1979; 300: 1459-1468.
78. Pak CY, Poindexter JR, Adams-Huet B, Pearle MS. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 2003; 115: 26-32.
79. Tiselius HJ, Almegard LE, Larsson L, Sorbo B. A biochemical basis for grouping of patients with Urolithiasis. Eur Urol 1978; 4: 241-249.
80. Robertson WG, Peacock M, Heyburn PJ, Marshall H, Clark PB. Risk factors in calcium stone disease of the urinary tract. Br J Urol 1978; 50: 449-454.
81. Robertson WG, Qunibi W, Husain I, Hughes H, Walker VR, Taher S et al. The calculation of stone risk in the urine of middle eastern men and women expatriates living in Saudi Arabia. In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG, editors. Urolithiasis. New York, London: Plenum Press; 1989. p. 669-671.
82. Ryall RL, Harnett RM, Hibberd CM, Mazzachi BC, Mazzachi RD, Marshall VR. Urinary risk factors in calcium oxalate stone disease comparison of Men and Women. Br J Urol 1987; 60: 480-488.
83. Tiselius HG, Almegard LE. The Diurinal urinary excretion of oxalate and the effect of Pyridoxine and Ascorbate on oxalate excretion. Eur Urol 1977; 3: 41-46.
84. Huang HS, Ma MC, Chen CF, Chen J. Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. J Urol 2003; 62: 1123-1128.
85. Ryall RL, Darroch JN, Marshall VR. The Evaluation of Risk Factors in Male Stone Formers attending a General Out-Patient Clinic. Br J Urol 1984; 56: 116-121.
86. Lewandowski S, Rodgers AL. Idiopathic calcium oxalate Urolithiasis: risk factors and conservative treatment. Clin Chim Acta 2004; 345: 17-34.
87. Dean BM, Watts RWE, Westwick WJ. The metabolism of (1-14c) glyoxylate, (1-14c) glycolate (1-14c) glycine and (2-14c)glycine by homogenates of kidney and liver tissue from hyperoxaluric and control subjects. Biochem J 1967; 105: 701-707.
88. Rodgers A. Aspects of calcium oxalate crystallization: theory, in vitro studies, and in vivo implementation. J Am Soc Nephrol 1999; 14: 351-354.
89. Robertson WG, Nisa M, Husain I, Al-Faqih S, Chakrabarty A, Qunibi W, et al. The Importance of Diet in the Etiology of Primary calcium and uric acid stone formation: the Arabian experience. In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG, editors. Urolithiasis. New York, London: Plenum Press; 1989. p. 735-739.
90. Juuti M, Alhava EM. Excretion of urinary calcium and oxalate on three diets in patients with urolithiasis. Ann Clin Res 1980; 12: 320-325.
91. Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol 2000; 13: 45-50.
92. Tiselius HG, Larsson L. Validity of biochemical findings in the evaluation of patients with Urolithiasis. Eur Urol 1980; 6: 90-94.
93. Tiselius HG. Relationship between the severity of renal stone disease and urine composition. Eur Urol 1979; 5: 323-327.
94. Ahlstrand C, Larsson L, Tiselius HG. Variations in urine composition during the day in patients with calcium oxalate stone disease. J Urol 1984; 131: 77-81.
95. Pierratos A, Dharamsi N, Carr LK, Ibanez D, Jewett MAS, Honey RJDA. Higher urinary potassium is associated with decreased stone growth after shock wave lithotripsy. J Urol 2000; 164: 1486-1489.
96. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Family history and risk of kidney stones. J Am Soc Nephrol 1997; 8: 1568-1573.
97. Bytyci X, Mesaric S. Epidemiological investigation of nephrolithiasis in the region of Sap kosovo in yugoslavia. In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG, editors. Urolithiasis. New York, London: Plenum Press; 1989. p. 699.
98. Lee YH, Huang WC, Lu CM, Tsai JY, Huang JK. Stone recurrence predictive score (SRPS) for patients with calcium oxalate stones. J Urol 2003; 170: 404-407.
99. Trinchieri A. Epidemiology of urolithiasis. Arch Ital Urol Androl 1996; 68: 203-249.
100. Curhan GC, Willett WC, Rimm EB, Speizer FE, Stampfer MJ. Body size and risk of kidney stones. J Amer Soc Nephrol 1998; 9: 1645-1652.
101. Siener R, Glatz S, Nicolay C, Hesse A. The role of overweight and obesity in calcium oxalate stone formation. Obes Res 2004; 12: 106-113.
102. Nishio S, Yokoyama M, Iwata H, Takeuchi M, Kamei O, Sugamoto T, et al. Obesity as one of the risk factors for Urolithiasis. Nippon Hinyokika Gakkai Zasshi 1998; 89: 573-580.
103. Vagelli G, Galabrose G, Ferraris V, Mazzotta A, Pratesi G, Gonella M. Overweight and calcium stone disease. In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG, editors. Urolithiasis. London, New York: Plenum Press; 1989; 759-760.
104. Shen M, Shi L, Li L, Zhang S, Zhang C, Jiang Y. A case control study on urinary calculi and dietary factors. Zhonghua Liu Xing Bing Xue Za Zhi 2002; 23: 143-137.
105. Al Zahrani H, Norman RW, Thompson C, Weerasinghe S. The dietary habits of idiopathic calcium stone formers and normal control subjects. BJU Int 2000; 85: 616-620.
106. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993; 328: 833-838.
107. Curhan GC, Willett WC, Knight EL, Stampfer MJ. Dietary factors and the risk of incident kidney stones in younger women: Nurses health study II. Arch Intern Med 2004; 164: 885-891.
108. Bailly GG, Norman RW, Thompson C. Effects of dietary fat on the urinary risk factors of calcium stone disease. Urology 2000; 56: 40-44.
109. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 1997; 126: 497-504.
110. Rofe AM, Bais R, Conyers RAJ. The effect of dietary refined sugars and sugar alcohols on renal calcium oxalate deposition in ethylene glycol-treated rats. Food Chem Toxicol 1986; 24: 397-403.
111. Curhan GC. Dietary calcium, dietary protein, and kidney stone formation. Miner Electrolyte Metab 1997; 23: 261-264.
112. von Unruh GE, Voss S, Sauerbruch T, Hesse A. Dependence of oxalate absorption on the daily calcium intake. J Am Soc Nephrol 2004; 15: 1567-1573.
113. Curhan GC, Curhan SG. Dietary factors and kidney stone formation. Compr Ther 1994; 20: 485-489.
114. Trinchieri A, Nespoli R, Ostini F, Rovera F, Zanetti G, Pisani E. A study of dietary calcium and other nutrients in idiopathic renal calcium stone formers with low bone mineral content. J Urol 1998; 159: 654-657.
115. Caudarella R, Rizzoli E, Buffa A, Bottura A, Stefoni S. Comparative study of the influence of 3 types of mineral water in patients with idiopathic calcium lithiasis. J Urol 1998; 159: 658-663.
116. Coen G, Sardella D, Barbera G, Ferrannini M, Comegna C, Ferazzoli F, et al. Urinary composition and lithogenic risk in normal subjects following oligomineral versus bicarbonate-alkaline high calcium mineral water intake. Urol Int 2001; 67: 49-53.
117. De Swart PMJR, Busemann Sokole E, Wilmink JM. The interrelationship of calcium and magnesium absorption in idiopathic hypercalciuria and renal calcium stone disease. J Urol 1998; 159: 669-672.
118. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Intake of vitamins B6 and C and the risk of kidney stones in women. J Am Soc Nephrol 1999; 10: 840-845.
119. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men. J Urol 1996; 155: 1847-1851.
120. Drach GW. Evaluation of urinary stone formers. Semin Urol 1984; 11: 12-19.
121. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. b N Engl J Med 2002; 346: 77-84.
122. Ilievski P, Nakovski R, Jankovski V, Ilievska S, Janevski B. Soft Drinking Water and Urolithiasis. In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG, editors. Urolithiasis. London, New York: Plenum Press; 1989. p. 773.
123. Ilievski PM, Ilievska SS. Drinking water quality and urolithiasis. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W, editors. Urolithiasis and related clinical research. New York, London: Plenum Press; 1985. p. 105-107.
124. Singh PP, Kiran R, Pendse AK, Mathur HN. Bearing of drinking water quality on the prevalence of urolithiasis. In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG, editors. Urolithiasis. London, New York: Plenum Press; 1989; 771-772.
125. Bellizzi V, De Nicola L, Minutolo R, Russo D, Cianciaruso B, Andreucci M, et al. Effects of water hardness on urinary risk factors for kidney stones in patients with idiopathic nephrolithiasis. Nephron 1999; 81: 66-70.
126. Vahlensieck W. Influence of water quality on urolithiasis. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W, editors. Urolithiasis and related clinical research. New York, London: Plenum Press; 1985. p. 97-103.
127. Robertson WG, Peacock M, Nordin BEC. Inhibitors of growth and aggregation of calcium oxalate crystal in vitro. Clin Chim Acta 1973; 43: 31-37.
128. Soygur T, Akbay A, Kupeli S. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J Endourol 2002; 16: 149-152.
129. Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 1997; 158: 2069-2073.
130. Worcester EM. Inhibitors of stone formation. Semin Nephrol 1996; 16: 474-486.
131. Martelli A, Marchesini B, Buli P, Lambertini F, Rusconi R. Urinary excretion pattern of main glycosaminoglycan of stone formers and controls, In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W, editors. Urolithiasis and Related Clinical Research. New York, London: Plenum Press; 1985. p. 355-358.
132. Michelacci YM, Glashan RQ, Schor N. Urinary excretion of Glycosaminoglycans in normal and stone forming subjects. Kidney Inter 1989; 30: 1022-1028.
133. Sidhu H, Hemal AK, Vaidyanathan S, Thind SK, Nath R. Correlation of urinary excretion of glycosaminoglycans and uric acid in healthy adults and in renal stone formers. Urol Res 1988; 16: 233.
134. Caudarella E, Pizzoli G, Martelli G, Barveglieri F, Malavolta N. Urinary excretion of glycosaminoglycans in calcium lithiasis. The role of protein intake. Urol Res 1988; 16: 206.
135. Fellstrom B, Danielson BG, Karlstrom B, Lithell H, Ljunghall S, Vessby B, et al. Effects of high intake of dietary animal protein on mineral metabolism and urinary supersaturation of calcium oxalate in renal stone formers. Br J Urol 1984; 56: 263-269.
136. Suzuki M, Kobayashi H, Kageyama S, Shibata K, Fujie M, Terao T. Excretion of bikunin and its fragments in the urine of patients with renal stones. J Urol 2001; 166: 268-274.
137. Al-Hadramy MS. Seasonal variations of urinary stone colic in Arabia. J Pak Med Assoc 1997; 47: 281-284.
138. Sarmina I, Spirnak PJ, Resnick MI. Urinary lithiasis in the black population: An epidemiological study and review of the literature. J Urol 1987; 138: 14-17.
139. Stuart RO 2nd, Hill K, Poindexter J, Pak CY. Seasonal variations in urinary risk factors among patients with nephrolithiasis. J Lithotr Stone Dis 1991; 3: 18-27.
140. Kleiner SM. Water: An essential but overlooked nutrient. J Amer Diet Assoc 1999; 99: 200-206.
141. Garcia Matilla F, Garcia Montes F, Ribas Serna J. Aqueous diuresis and prophylaxis of recurrent nephrolithiasis. Actas Urol Esp 1999; 23: 296-308.
142. Hiatt RA, Ettinger B, Caan B, Quesenberry CP Jr, Duncan D, Citron JT. Randomized controlled trial of a low animal protein high fiber diet in the prevention of recurrent calcium oxalate kidney stones. Am J Epidemiol 1996; 144: 25-33.